{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:00:49Z","timestamp":1768741249861,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.maturitas.2004.06.020","type":"journal-article","created":{"date-parts":[[2004,10,13]],"date-time":"2004-10-13T13:53:41Z","timestamp":1097675621000},"page":"267-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Postmenopausal testosterone therapy and breast cancer risk"],"prefix":"10.1016","volume":"49","author":[{"given":"Woraluk","family":"Somboonporn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan R","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.maturitas.2004.06.020_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1043-2760(00)00254-X","article-title":"The role of local estrogen biosynthesis in males and females","volume":"11","author":"Simpson","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0378-5122(84)90008-2","article-title":"The management of persistent menopausal symptoms with oestradiol\u2013testosterone implants: clinical, lipid and hormonal results","volume":"6","author":"Burger","year":"1984","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2004.06.020_bib3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bmj.294.6577.936","article-title":"Effect of combined implants of estradiol and testosterone on libido in postmenopausal women","volume":"294","author":"Burger","year":"1987","journal-title":"Br. Med. J."},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0378-5122(94)00898-H","article-title":"Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality","volume":"21","author":"Davis","year":"1995","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.maturitas.2004.06.020_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-9378(85)90001-8","article-title":"Differential symptom response to parenteral estrogen and\/or androgen administration in the surgical menopause","volume":"151","author":"Sherwin","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00006842-198507000-00004","article-title":"Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in surgical menopause","volume":"47","author":"Sherwin","year":"1985","journal-title":"Psychosom. Med."},{"issue":"2","key":"10.1016\/j.maturitas.2004.06.020_bib7","first-page":"98","article-title":"Use of combined estrogen\u2013androgen preparations in the postmenopause: evidence from clinical studies","volume":"43","author":"Sherwin","year":"1998","journal-title":"Int. J. Fertil. Womens Med."},{"issue":"Suppl. 4","key":"10.1016\/j.maturitas.2004.06.020_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0015-0282(02)03002-9","article-title":"Randomized clinical trials of combined estrogen\u2013androgen preparations: effects on sexual functioning","volume":"77","author":"Sherwin","year":"2002","journal-title":"Fertil. Steril."},{"issue":"10","key":"10.1016\/j.maturitas.2004.06.020_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM200009073431002","article-title":"Transdermal testosterone treatment in women with impaired sexual function after oophorectomy","volume":"343","author":"Shifren","year":"2000","journal-title":"N. Eng. J. Med."},{"issue":"24","key":"10.1016\/j.maturitas.2004.06.020_bib10","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"J. Am. Med. Assoc."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0015-0282(02)02984-9","article-title":"Aromatization of androgens in women: current concepts and findings","volume":"77","author":"Simpson","year":"2002","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.maturitas.2004.06.020_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1210\/jcem-60-1-174","article-title":"Effects of aging and obesity on aromatase activity of human adipose cells","volume":"60","author":"Cleland","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.maturitas.2004.06.020_bib15","first-page":"428","article-title":"Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome p450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age","volume":"78","author":"Bulun","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"25","key":"10.1016\/j.maturitas.2004.06.020_bib16","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/0024-3205(92)90112-3","article-title":"Increase of plasma IL-6 concentration with age in healthy subjects","volume":"51","author":"Wei","year":"1992","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.maturitas.2004.06.020_bib17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jbmr.5650090821","article-title":"Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women","volume":"9","author":"McKane","year":"1994","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib18","first-page":"601","article-title":"Androgen and estrogen dynamics: relationships with age, weight, and menopausal status","volume":"76","author":"Longcope","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20135","key":"10.1016\/j.maturitas.2004.06.020_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0960-0760(01)00154-6","article-title":"The potential role of estrogen in aromatase regulation in the breast","volume":"79","author":"Yue","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib20","first-page":"1432","article-title":"The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal nonhuman primate mammary gland","volume":"84","author":"Nakamura","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.maturitas.2004.06.020_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF01187162","article-title":"Aromatase in breast cancer tissue\u2014localization and relationship with reproductive status of patients","volume":"122","author":"Berstein","year":"1996","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/JCO.1992.10.3.438","article-title":"Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging","volume":"10","author":"Bolufer","year":"1992","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib23","first-page":"1460","article-title":"Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients","volume":"81","author":"Pasqualini","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2004.06.020_bib24","first-page":"103","article-title":"Effects of sex steroids on skin 5 alpha-reductase activity in vitro","volume":"78","author":"Cassidenti","year":"1991","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.maturitas.2004.06.020_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-4731(85)90236-5","article-title":"The effect of spironolactone on genital skin 5 alpha-reductase activity","volume":"23","author":"Serafini","year":"1985","journal-title":"J. Steroid Biochem."},{"issue":"1","key":"10.1016\/j.maturitas.2004.06.020_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0015-0282(16)49094-1","article-title":"Prolactin modulates peripheral androgen metabolism","volume":"45","author":"Serafini","year":"1986","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pros.2990060303","article-title":"Inhibition of androgen metabolism in stroma and epithelium of the human benign prostatic hyperplasia by progesterone, estrone, and estradiol","volume":"6","author":"Krieg","year":"1985","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.maturitas.2004.06.020_bib28","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jcem-51-5-1107","article-title":"Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol","volume":"51","author":"Kuttenn","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.maturitas.2004.06.020_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0039-128X(84)90055-2","article-title":"The effect of five synthetic progestational compounds on 5 alpha-reductase activity in genital skin fibroblast monolayers","volume":"43","author":"Dean","year":"1984","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib30","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/bjc.1993.111","article-title":"Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status","volume":"67","author":"Clarke","year":"1993","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2004.06.020_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1005805831460","article-title":"Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression","volume":"45","author":"Clarke","year":"1997","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.maturitas.2004.06.020_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1210\/endo.136.1.7828527","article-title":"The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone","volume":"136","author":"Laidlaw","year":"1995","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.maturitas.2004.06.020_bib33","first-page":"162","article-title":"Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation","volume":"51","author":"Kyprianou","year":"1991","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF02307030","article-title":"Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells","volume":"2","author":"Perry","year":"1995","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.maturitas.2004.06.020_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0303-7207(02)00105-3","article-title":"Breast cancer: from estrogen to androgen receptor","volume":"193","author":"Ando","year":"2002","journal-title":"Mol. Cell Endocrinol."},{"issue":"6","key":"10.1016\/j.maturitas.2004.06.020_bib36","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/bjc.1994.444","article-title":"5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol","volume":"70","author":"Boccuzzi","year":"1994","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2004.06.020_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/gye.16.2.113.120","article-title":"Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines","volume":"16","author":"Ortmann","year":"2002","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib38","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/jcem-53-4-836","article-title":"An antiestrogenic action of androgens in human breast cancer cells","volume":"53","author":"MacIndoe","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.maturitas.2004.06.020_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0960-0760(95)00005-K","article-title":"Androgens induce divergent proliferative responses in human breast cancer cell lines","volume":"52","author":"Birrell","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.maturitas.2004.06.020_bib40","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1042\/bst0241059","article-title":"Cell death signal transduction and bcl-2 function","volume":"24","author":"Herrmann","year":"1996","journal-title":"Biochem. Soc. Trans."},{"issue":"8","key":"10.1016\/j.maturitas.2004.06.020_bib41","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/carcin\/20.8.1597","article-title":"Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens","volume":"20","author":"Xie","year":"1999","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.maturitas.2004.06.020_bib42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/endo.140.1.6410","article-title":"Androgens down-regulate bcl-2 protooncogene expression in ZR-75-1 human breast cancer cells","volume":"140","author":"Lapointe","year":"1999","journal-title":"Endocrinology"},{"issue":"1\u20136","key":"10.1016\/j.maturitas.2004.06.020_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0960-0760(99)00069-2","article-title":"Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells","volume":"69","author":"Kandouz","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"7","key":"10.1016\/j.maturitas.2004.06.020_bib44","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.1995.13.7.1572","article-title":"Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression","volume":"13","author":"Birrell","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.maturitas.2004.06.020_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1006400732154","article-title":"Sex hormone-induced mammary carcinogenesis in the female Noble rats: expression of bcl-2 and bax in hormonal mammary carcinogenesis","volume":"61","author":"Xie","year":"2000","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1071-5576(00)00059-9","article-title":"Effects of an oral contraceptive combination with or without androgen on mammary tissues: a study in rats","volume":"7","author":"Jayo","year":"2000","journal-title":"J. Soc.. Gynecol. Invest."},{"issue":"12","key":"10.1016\/j.maturitas.2004.06.020_bib47","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1096\/fj.99-0863com","article-title":"Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression","volume":"14","author":"Zhou","year":"2000","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.GME.0000055522.67459.89","article-title":"A physiologic role for testosterone in limiting estrogenic stimulation of the breast","volume":"10","author":"Dimitrakakis","year":"2003","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01806301","article-title":"Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat","volume":"14","author":"Dauvois","year":"1989","journal-title":"Breast Cancer Res. Treat."},{"issue":"12","key":"10.1016\/j.maturitas.2004.06.020_bib50","first-page":"3131","article-title":"Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice","volume":"51","author":"Dauvois","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.maturitas.2004.06.020_bib51","first-page":"471","article-title":"Androgens and breast cancer in premenopausal women","volume":"49","author":"Secreto","year":"1989","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.maturitas.2004.06.020_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ijc.11034","article-title":"Plasma sex steroid hormones and breast cancer risk in Chinese women","volume":"105","author":"Yu","year":"2003","journal-title":"Int. J. Cancer."},{"issue":"5","key":"10.1016\/j.maturitas.2004.06.020_bib53","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/oxfordjournals.aje.a114596","article-title":"Sex hormone levels in serum in relation to the development of breast cancer","volume":"125","author":"Wysowski","year":"1987","journal-title":"Am. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.maturitas.2004.06.020_bib54","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/bjc.1997.183","article-title":"A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey","volume":"75","author":"Thomas","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib55","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1471-0528.1991.tb13396.x","article-title":"Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries","volume":"98","author":"Fox","year":"1991","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib56","first-page":"403","article-title":"Chronic anovulation syndrome and associated neoplasia","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib57","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<494::AID-CNCR10>3.0.CO;2-Z","article-title":"Association of Stein\u2013Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa","volume":"79","author":"Anderson","year":"1997","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.maturitas.2004.06.020_bib58","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/oxfordjournals.aje.a116156","article-title":"Polycystic ovaries and the risk of breast cancer","volume":"134","author":"Gammon","year":"1991","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.maturitas.2004.06.020_bib59","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00001648-199601000-00017","article-title":"Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer","volume":"7","author":"Lipworth","year":"1996","journal-title":"Epidemiology"},{"key":"10.1016\/j.maturitas.2004.06.020_bib60","first-page":"2572","article-title":"Serum and urinary androgens and risk of breast cancer in postmenopausal women","volume":"51","author":"Secreto","year":"1991","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.maturitas.2004.06.020_bib61","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/oxfordjournals.aje.a116228","article-title":"Sex hormones and postmenopausal breast cancer: a prospective study in an adult community","volume":"135","author":"Garland","year":"1992","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.maturitas.2004.06.020_bib62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jnci\/88.5.291","article-title":"Serum sex hormone levels after menopause and subsequent breast cancer","volume":"88","author":"Berrino","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.maturitas.2004.06.020_bib63","first-page":"533","article-title":"Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk","volume":"5","author":"Dorgan","year":"1996","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"3","key":"10.1016\/j.maturitas.2004.06.020_bib64","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/bjc.1997.398","article-title":"A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey","volume":"76","author":"Thomas","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.maturitas.2004.06.020_bib65","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/oxfordjournals.aje.a009059","article-title":"Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women","volume":"145","author":"Zeleniuch-Jacquotte","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.maturitas.2004.06.020_bib66","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jnci\/90.17.1292","article-title":"Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women","volume":"90","author":"Hankinson","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"4 pt 1","key":"10.1016\/j.maturitas.2004.06.020_bib67","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00004","article-title":"Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group","volume":"130","author":"Cauley","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.maturitas.2004.06.020_bib68","first-page":"599","article-title":"Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)","volume":"14","author":"Manjer","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.maturitas.2004.06.020_bib69","doi-asserted-by":"crossref","unstructured":"Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies, J Natl Cancer Inst 2002;94(8):606\u201316.","DOI":"10.1093\/jnci\/94.8.606"},{"issue":"20","key":"10.1016\/j.maturitas.2004.06.020_bib70","first-page":"6571","article-title":"Dehydroepiandrosterone sulfate and breast cancer risk","volume":"50","author":"Barrett-Connor","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.maturitas.2004.06.020_bib71","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0025-6196(19)30637-8","article-title":"Techniques to measure testosterone in the elderly","volume":"75","author":"Klee","year":"2000","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.maturitas.2004.06.020_bib72","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ijc.2910420606","article-title":"Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Demnark","volume":"42","author":"Ewertz","year":"1988","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.maturitas.2004.06.020_bib73","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bjc.1986.246","article-title":"Menopausal oestrogens, and breast cancer risk: an expanded study case-control study","volume":"54","author":"Brinton","year":"1986","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.maturitas.2004.06.020_bib74","unstructured":"Dimitrakakis C, Jones R, Liu A, Bondy C. Breast cancer incidence in Australian women using testosterone in addition to estrogen replacement. In: Proceedings of the 85th Annual Meeting of the Endocrine Society. Philadelphia, MD: The Endocrine Society Press; 2003."},{"issue":"660","key":"10.1016\/j.maturitas.2004.06.020_bib75","first-page":"665","article-title":"Female androgen insufficiency: the Princeton Consensus Statement on definition, classification and assessment","volume":"77","author":"Bachmann","year":"2002","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.maturitas.2004.06.020_bib76","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-0327(88)90061-4","article-title":"Affective changes with estrogen and androgen replacement therapy in surgically menopausal women","volume":"14","author":"Sherwin","year":"1988","journal-title":"J. Affect Disord."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib77","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0015-0282(02)02969-2","article-title":"Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment","volume":"77","author":"Bachmann","year":"2002","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.maturitas.2004.06.020_bib78","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/annonc\/mdg169","article-title":"Cancer prevalence in the UK: results from the EUROPREVAL study","volume":"14","author":"Forman","year":"2003","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.maturitas.2004.06.020_bib79","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/cncr.10593","article-title":"Annual report to the nation on the status of cancer, 1973\u20131999, featuring implications of age and aging on US cancer burden","volume":"94","author":"Edwards","year":"2002","journal-title":"Cancer"},{"issue":"9382","key":"10.1016\/j.maturitas.2004.06.020_bib80","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"issue":"7440","key":"10.1016\/j.maturitas.2004.06.020_bib81","first-page":"602","article-title":"Oestrogen only arm of women's health initiative trial is stopped","volume":"328","author":"Hopkins","year":"2004","journal-title":"BMJ"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512204002245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512204002245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:38:55Z","timestamp":1759912735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512204002245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0378512204002245"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2004.06.020","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postmenopausal testosterone therapy and breast cancer risk","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2004.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}